With the launch of Alprolix in May and Eloctate coming in July, Biogen Idec is on the leading edge of the first new class of hemophilia treatments to come along in 15 years. The question is, how interested are justifiably cautious patients in trying new things? Although hemophilia is fairly well-known due to its presence in some of Europe’s royal families, the disease is actually rare. Novo Nordisk (NVO) estimates that there are fewer than 500,000
Danish drug giant Novo Nordisk missed Q1 sales estimates and lowered its full-year revenue forecast Thursday, as the loss of support from U.S. payers hurt. The stock fell 2.9%. Novo Nordisk (NVO) made 45 cents a share in the quarter, up about 10% over the year-earlier quarter in Danish kroner, and a penny above analysts’ consensus. Sales increased 7% in local currencies to the equivalent of $3.73 billion, missing consensus of $3.97 billion. The
Danish pharmaceutical giant Novo Nordisk (NVO) missed Q1 sales estimates and lowered its full-year revenue forecast Thursday, though profit was in line. Novo stock was down more than 2% in early trading on the stock market today. Novo made 45 cents a share in the quarter, up about 10% over the year-earlier quarter in Danish kroner, and a penny above analysts’ consensus. Sales increased 2% in kroner to the equivalent of $3.73 billion, missing